| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 03/17/2005 | WO2005023287A1 Skin ulcer preventive curative agent containing human recombinant hgf |
| 03/17/2005 | WO2005023176A2 Delivery of physiologixal agents with in-situ gels comprising anionic polysaccharides |
| 03/17/2005 | WO2005007184A3 Cyclic analogs of human parathyroid hormone for the treatment of conditions characterized by hyperproliferative skin cells |
| 03/17/2005 | WO2004056809A8 Novel piperidine derivatives as modulators of chemokine receptor ccr5 |
| 03/17/2005 | WO2004056808A8 Novel piperidine derivatives as modulators of chemokine receptor ccr5 |
| 03/17/2005 | WO2002050028A8 Substituted benzoindoles as spla2 inhibitors |
| 03/17/2005 | US20050059740 Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders |
| 03/17/2005 | US20050059714 2-Cyclopropyl-4-(5-fluoro-2-methoxyphenyl)-4-methyl-1-(1H-pyrrolo[2,3-c]pyridin-2-yl)pentan-2-ol; treating diseases of inflammatory, allergic, or proliferative condition; type II diabetes, obesity, cardiovascular diseases, hypertension, arteriosclerosis, neurological diseases, adrenal and pituitary tumor |
| 03/17/2005 | US20050059712 Immunosuppressants for treating skin disorders, acne, alopecia, estrogen- or androgen-dependent tumors, rheumatoid arthritis, type I and II diabetes, lupus erythematosus, multiple sclerosis, ulcerative colitis, Crohn's disease, psoriasis, contact dermatitis, graft versus host disease, eczema, asthma |
| 03/17/2005 | US20050059710 Diphenylamino ketone derivatives as MEK inhibitors |
| 03/17/2005 | US20050059699 N-acylated lipophilic amino acid derivatives |
| 03/17/2005 | US20050059694 Antiinflammatory and antiproliferative skin agents for Topical administration of treating skin psoriasis disease; lotions, gels, cream |
| 03/17/2005 | US20050059686 Pyrrolopyrimidines as phosphodiesterase vII inhibitors |
| 03/17/2005 | US20050059685 such as R)-1,5-Dimethyl 3-(5-hydroxyhexyl)pyrido[2,3-d]pyrimidine-2,4,7(1H,3H,8H)-trione, used for the treatment or prevention of symptoms or manifestations associated with diseases or disorders affected by cytokine intracellular signaling |
| 03/17/2005 | US20050059666 CCR5 antagonists useful for treating AIDS |
| 03/17/2005 | US20050059665 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 03/17/2005 | US20050059657 Aminoisoxazole derivatives active as kinase inhibitors |
| 03/17/2005 | US20050059644 Including one or more anesthetic agents and/or one or more anti-inflammatory agents and/or a combination of ammonium, sodium, and potassium salts, preferably of an alpha-hydroxy acid |
| 03/17/2005 | US20050059625 Immunostimulatory nucleic acid molecules |
| 03/17/2005 | US20050059616 administering flavonoids and optionally vitamin E or excipients for the prophylaxis of bone or cardiovascular disorders, headaches, hypertension, cancers, leukemia, arteriosclerosis, Alzheimer's disease, inflammatory diseases, rheumatic diseases, acne, alopecia or psoriasis |
| 03/17/2005 | US20050059093 Method for detecting modulators of Notch signalling |
| 03/17/2005 | US20050059081 Dipeptidyl peptidase IV (DPPIV); homology with family of prolyl oligopeptidases; drug screening for enzyme inhibitors for DPPIV which could treat reproductive, inflammatory and metabolic disorders; antibodies for therapeutic or diagnostic use; host cells |
| 03/17/2005 | US20050058767 Process for accelerating recovery from trauma by using apoptosis-mimicking synthetic or natural entities |
| 03/17/2005 | US20050058679 Cosmetic preparation with 2-methyl-1,3-propanediol, or pentanediol or hexanediol with antioxidant and uv filter for skin moisturizer |
| 03/17/2005 | US20050058639 Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof |
| 03/17/2005 | DE10337863A1 Verwendung von Chromen-4-on-Derivaten The use of chromene-4-one derivatives |
| 03/17/2005 | DE10337862A1 Chromen-4-on-Derivate Chromen-4-one derivatives |
| 03/17/2005 | CA2537290A1 Delivery of physiological agents with in-situ gels comprising anionic polysaccharides |
| 03/17/2005 | CA2537246A1 Skin ulcer preventive or curative agent containing human recombinant hgf |
| 03/16/2005 | EP1514872A1 Phosphorylated glyceryl ether aluminium salts |
| 03/16/2005 | EP1514867A2 Substituted phenyl derivatives, their preparation and use |
| 03/16/2005 | EP1514544A1 Antiallergic |
| 03/16/2005 | EP1514537A2 Anti-aging agent and collagen production promoter |
| 03/16/2005 | EP1514536A1 Topical compositions |
| 03/16/2005 | EP1513880A1 Epimerized derivatives of k5 polysaccharide with a very high degree of sulfation |
| 03/16/2005 | EP1513839A1 3-substituted quinuclidines and their use |
| 03/16/2005 | EP1513837A1 Thiazole derivatives as phosphodiesterase iv inhibitors |
| 03/16/2005 | EP1513836A1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 03/16/2005 | EP1513835A1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 03/16/2005 | EP1513830A1 Bisindolyl-maleimid derivatives as kinase inhibitors |
| 03/16/2005 | EP1513827A1 1,3,5-triazine derivatives as ligands for human adenosine-a3 receptors |
| 03/16/2005 | EP1513826A1 New indolylpiperidine derivatives as potent antihistaminic and antiallergic agents |
| 03/16/2005 | EP1513821A1 Protein kinase inhibitors |
| 03/16/2005 | EP1513820A2 Compounds, compositions, and methods |
| 03/16/2005 | EP1513810A1 4-(aryl or heteroaryl) -2-butylamine derivatives and their use as glucocorticoid ligans |
| 03/16/2005 | EP1513803A1 Ligands that are inhibitors of the rar receptors |
| 03/16/2005 | EP1513793A1 Novel ligands that are inhibitors of the rar receptors, process for preparing them and use thereof in human medicine and in cosmetics |
| 03/16/2005 | EP1513560A2 Method of magnetically manipulating a cell with magnetisable particles |
| 03/16/2005 | EP1513546A1 Compositions for therapeutic use comprising a vitamin, a metal salt and insulin or a growth hormone |
| 03/16/2005 | EP1513542A2 Anti-cancer and wound healing compounds |
| 03/16/2005 | EP1513536A1 Use of compounds that stimulate cgmp |
| 03/16/2005 | EP1513531A1 Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom |
| 03/16/2005 | EP1513524A2 Ether substituted imidazopyridines |
| 03/16/2005 | EP1513522A2 Methods of treating conditions associated with an edg receptor |
| 03/16/2005 | EP1513520A2 Substituted pyrrolines as kinase inhibitors |
| 03/16/2005 | EP1513516A1 SUBSTITUTED 3-AMINO-THIENO(2,3-b) PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS ANDPROCESSES FOR PREPARING AND THEIR USES |
| 03/16/2005 | EP1513482A2 Topical use of at least one double-stranded rna oligonucleotide (ds rna) |
| 03/16/2005 | EP1513419A2 Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress |
| 03/16/2005 | EP1470216A4 Hair follicle growth |
| 03/16/2005 | EP1435899A4 A composition for promoting hair growth |
| 03/16/2005 | EP1351647A4 Compositions and methods for treating hyperpigmentation |
| 03/16/2005 | EP1339421B1 Cosmetic and/or dermopharmaceutical preparations containing native proteins from the plant argania spinosa |
| 03/16/2005 | EP1250358B1 Therapeutic peptides |
| 03/16/2005 | EP1233959B1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
| 03/16/2005 | EP1226119B1 Tyrosine kinase inhibitors |
| 03/16/2005 | EP1198508B1 Preparations containing no cross-linking agents |
| 03/16/2005 | EP1171143B9 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising same |
| 03/16/2005 | EP1146873B1 Anti-androgens and methods for treating disease |
| 03/16/2005 | EP1140900B1 Pyrazole compounds and uses thereof |
| 03/16/2005 | EP1117296B1 Combination of bisphosphonate and tetracycline |
| 03/16/2005 | EP0965327B1 Wrinkling modifiers |
| 03/16/2005 | CN1596266A Specific binding agents of human angiopoietin-2 |
| 03/16/2005 | CN1596263A Aryl fused azapolycyclic compounds |
| 03/16/2005 | CN1596257A Novel crystalline compound |
| 03/16/2005 | CN1596255A Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 03/16/2005 | CN1596254A Process for the prereparation of compositions having an increased amount of pharmaceutically active salts of rotamers |
| 03/16/2005 | CN1596253A Spiro-hydantoin compounds useful as anti-inflammatory agents |
| 03/16/2005 | CN1596249A Benzoxazine and benzothiazine derivatives and parmaceutical compositions containing them |
| 03/16/2005 | CN1596240A Chalcone derivatives and their use to treat diseases |
| 03/16/2005 | CN1596127A Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound |
| 03/16/2005 | CN1596122A Pharmaceutical composition comprising factor vii polypeptides and pai-1 polypeptides |
| 03/16/2005 | CN1596115A Treatment of hyperproliferative diseases using active vitamin D analogues |
| 03/16/2005 | CN1596114A Substituted 1, 4-benzodiazepines and uses thereof for the treatment of cancer |
| 03/16/2005 | CN1593652A Usage of human lysozyme in preparation of dermics |
| 03/16/2005 | CN1593638A Powdered Chinese medicine for treating burn and scald |
| 03/16/2005 | CN1593637A Chinese medicinal powder for treating skin ulcer and venereal disease |
| 03/16/2005 | CN1593618A Chinese medicinal powder with gall, giant knotweed, hyacinth bletilla and bornel |
| 03/16/2005 | CN1593617A Chinese patent medicine for promoting defecation to expelling toxin, nourishing skin and beautifying face |
| 03/16/2005 | CN1593613A Retch relieving liquor with bottle A and B |
| 03/16/2005 | CN1593610A Acne removing and skin rejuvenating cream |
| 03/16/2005 | CN1593593A Acne treating ointment |
| 03/16/2005 | CN1593579A Green peach hull and psoralea fruit containing liquor for treating leucoderma and alphos |
| 03/16/2005 | CN1593572A Alopecia treating traditional Chinese medicine preparation and its preparation process |
| 03/16/2005 | CN1593568A Medicine for treating burns, scalds, other multiple skin disease and traumatic injury |
| 03/16/2005 | CN1593540A Ointment for treating burns and scalds and its preparation |
| 03/16/2005 | CN1593539A Medicinal prescription for treating beriberi |
| 03/16/2005 | CN1593538A Burn and scald treating powder |
| 03/16/2005 | CN1593535A Externally applied Chinese traditional preparation for treating bedsore and its processing method |
| 03/16/2005 | CN1593501A Skin disease treating Chinese traditional medicine |
| 03/16/2005 | CN1593499A Medicine for treating boil, acute mastitis and acute inflammation |